Novel fibronectin mutations and expansion of the phenotype in spondylometaphyseal dysplasia with ""corner fractures""

Carregando...
Imagem de Miniatura
Citações na Scopus
10
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
COSTANTINI, Alice
VALTA, Helena
BARATANG, Nissan Vida
YAP, Patrick
CHEN, Jiani
WIERENGA, Klaas J.
FANNING, Elizabeth A.
Citação
BONE, v.121, p.163-171, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Heterozygous pathogenic variants in the FN1 gene, encoding fibronectin (FN), have recently been shown to be associated with a skeletal disorder in some individuals affected by spondylometaphyseal dysplasia with ""corner fractures"" (SMD-CF). The most striking feature characterizing SMD-CF is irregularly shaped metaphyses giving the appearance of ""corner fractures"". An array of secondary features, including developmental coxa vara, ovoid vertebral bodies and severe scoliosis, may also be present. FN is an important extracellular matrix component for bone and cartilage development. Here we report five patients affected by this subtype of SMD-CF caused by five novel FN1 missense mutations: p.Cys123Tyr, p.Cys169Tyr, p.Cys213Tyr, p.Cys23ITrp and p.Cys258Tyr. All individuals shared a substitution of a cysteine residue, disrupting disulfide bonds in the FN type-I assembly domains located in the N-terminal assembly region. The abnormal metaphyseal ossification and ""corner fracture"" appearances were the most remarkable clinical feature in these patients. In addition, generalized skeletal fragility with low-trauma bilateral femoral fractures was identified in one patient. Interestingly, the distal femoral changes in this patient healed with skeletal maturation. Our report expands the phenotypic and genetic spectrum of the FN1-related SMD-CF and emphasizes the importance of FN in bone formation and possibly also in the maintenance of bone strength.
Palavras-chave
FN1, Fibronectin, Skeletal dysplasia, Corner-fracture, Coxa vara, Mutation
Referências
  1. Ameur A, 2017, EUR J HUM GENET, V25, P1253, DOI 10.1038/ejhg.2017.130
  2. Aziz-Seible RS, 2011, WORLD J GASTROENTERO, V17, P2482, DOI 10.3748/wjg.v17.i20.2482
  3. Baydar DE, 2013, AM J KIDNEY DIS, V61, P514, DOI 10.1053/j.ajkd.2012.08.050
  4. Bentmann A, 2010, J BONE MINER RES, V25, P706, DOI 10.1359/jbmr.091011
  5. Brunner M, 2011, J CELL BIOL, V194, P307, DOI 10.1083/jcb.201007108
  6. Cadoff EB, 2018, CLIN GENET, V94, P429, DOI 10.1111/cge.13424
  7. Castelletti F, 2008, P NATL ACAD SCI USA, V105, P2538, DOI 10.1073/pnas.0707730105
  8. Crofton PM, 2002, CLIN CHEM, V48, P671
  9. Currarino G, 2000, PEDIATR RADIOL, V30, P14, DOI 10.1007/s002470050005
  10. Dallas SL, 2006, CURR TOP DEV BIOL, V75, P1, DOI 10.1016/S0070-2153(06)75001-3
  11. Faralli JA, 2009, EXP EYE RES, V88, P689, DOI 10.1016/j.exer.2008.08.019
  12. GEORGE EL, 1993, DEVELOPMENT, V119, P1079
  13. Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106
  14. Kawelke N, 2008, J BONE MINER RES, V23, P1278, DOI 10.1359/JBMR.080313
  15. Khalili AA, 2015, INT J MOL SCI, V16, P18149, DOI 10.3390/ijms160818149
  16. Kirschner R, 2011, J BIOL CHEM, V286, P32810, DOI 10.1074/jbc.M111.221804
  17. Koga A, 2008, SPINE, V33, P1318, DOI 10.1097/BRS.0b013e3181732a5d
  18. LANGER LO, 1990, RADIOLOGY, V175, P761, DOI 10.1148/radiology.175.3.2343127
  19. Laurent S, 2005, HYPERTENSION, V45, P1050, DOI 10.1161/01.HYP.0000164580.39991.3d
  20. Lausch E, 2009, AM J HUM GENET, V85, P168, DOI 10.1016/j.ajhg.2009.06.014
  21. Lee CS, 2017, AM J HUM GENET, V101, P815, DOI 10.1016/j.ajhg.2017.09.019
  22. Lee S, 2015, INT J MOL SCI, V16, P7672, DOI 10.3390/ijms16047672
  23. Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
  24. Li BJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02425
  25. Li H, 2013, 13033997 ARXIV, V1303, P3997, DOI 10.1093/BI0INF0RMATICS/BTP352
  26. Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
  27. Machol K, 2017, AM J MED GENET A, V173, P733, DOI 10.1002/ajmg.a.38059
  28. Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008
  29. McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4
  30. Mousa A, 2017, CELL DEATH DIFFER, V24, P844, DOI 10.1038/cdd.2017.21
  31. Nakchbandi IA, 2014, WORLD J GASTROENTERO, V20, P9427, DOI 10.3748/wjg.v20.i28.9427
  32. Ohtsubo H, 2016, PEDIATR NEPHROL, V31, P1459, DOI 10.1007/s00467-016-3368-7
  33. Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153
  34. Paiva KBS, 2017, PROG MOL BIOL TRANSL, V148, P203, DOI 10.1016/bs.pmbts.2017.05.001
  35. Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
  36. Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1
  37. Saidak Z, 2015, J BIOL CHEM, V290, P6903, DOI 10.1074/jbc.M114.621219
  38. Sens C, 2017, J BONE MINER RES, V32, P70, DOI 10.1002/jbmr.2916
  39. Sharony R, 2017, CLIN GENET, V92, P645, DOI 10.1111/cge.13020
  40. Shi F, 2011, J CELL SCI, V124, P4039, DOI 10.1242/jcs.087858
  41. Singh P, 2012, J CELL SCI, V125, P3703, DOI 10.1242/jcs.095786
  42. Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020
  43. Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048
  44. Spranger J. W., 2012, BONE DYSPLASIAS ATLA
  45. STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
  46. Tanaka AJ, 2015, AM J HUM GENET, V97, P457, DOI 10.1016/j.ajhg.2015.07.014
  47. Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI 10.1002/0471250953.bi1110s43
  48. Walter K, 2007, AM J MED GENET A, V143A, P161, DOI 10.1002/ajmg.a.31516
  49. Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603
  50. Zhang XR, 2012, CARTILAGE, V3, P267, DOI 10.1177/1947603511435273
  51. Zollinger AJ, 2017, MATRIX BIOL, V60-61, P27, DOI 10.1016/j.matbio.2016.07.011